Associate Director of National Intelligence and Chief Information Officer

How to Increase Patient Engagement in Your Clinical Trials, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, June 13, 2023
Patient engagement in Canada, Anxiety, Pain, Associate Director of National Intelligence and Chief Information Officer, Partnership, Pharma, Drug development, MD, Patient, Medtech, Caregiver, Medical imaging, Pharmaceutical industry, Nursing, Medical device

TORONTO, June 13, 2023 /PRNewswire-PRWeb/ -- Engaging with patients – and their caregivers and advocates – during the planning and execution of clinical trials is crucial. When patients are involved in the clinical development plan and creation of the trial protocol and are encouraged to provide in-trial feedback, they are more likely to stay in the trial, understand their responsibilities, and adhere to the protocol requirements. Working in partnership with patients can ensure impactful clinical benefit of treatments that address important unmet patient needs prioritized from the patient's perspective.

Key Points: 
  • Patient insights can be applied to many aspects of the clinical design and are ideally gathered and integrated as early as possible.
  • TORONTO, June 13, 2023 /PRNewswire-PRWeb/ -- Engaging with patients – and their caregivers and advocates – during the planning and execution of clinical trials is crucial.
  • However, lack of awareness, resources, and time to participate in patient engagement activities can negatively affect a company's ability to benefit from patient input.
  • In this webinar, our experts will review the range of tools that enable patient engagement during the clinical research stage of drug development.

FLORIDA SOUTHERN COLLEGE NAMES DR. LALY JOSEPH DEAN OF THE ANN BLANTON EDWARDS SCHOOL OF NURSING AND HEALTH SCIENCES

Retrieved on: 
Monday, June 12, 2023
Theta, Yoga, Mount Sinai Beth Israel, Associate Director of National Intelligence and Chief Information Officer, Phillips School of Nursing at Mount Sinai Beth Israel, University, MSN, Editorial Board at The Wall Street Journal, PSON, FDU, Qualitative Research (journal), Curriculum, Editorial board, NAP, Equity, APRN, BSN, Distinguished Fellow of the British Computer Society, Assistant, AACN, Fairleigh Dickinson University, Practitioner, DNP, Provost, National academy, Student, Florida Southern College, National League, Trustee, Outline of health sciences, CNE, National League for Nursing, Sigma, Faculty, Veterinary medicine, DVM, Approximation error, Phillips School, Nursing, Education

LAKELAND, Fla., June 12, 2023 /PRNewswire/ -- After an exhaustive national search, Florida Southern College has named Dr. Laly Joseph, DVM, DNP, CNE, RN-C, MSN, APRN, ANP-BC, FNAP, as the next Dean of the Ann Blanton Edwards School of Nursing and Health Sciences.

Key Points: 
  • LAKELAND, Fla., June 12, 2023 /PRNewswire/ -- After an exhaustive national search, Florida Southern College has named Dr. Laly Joseph, DVM, DNP, CNE, RN-C, MSN, APRN, ANP-BC, FNAP, as the next Dean of the Ann Blanton Edwards School of Nursing and Health Sciences.
  • Florida Southern College Names Dr. Laly Joseph New Dean of the Ann Blanton Edwards School of Nursing and Health Sciences
    The announcement was made by Dr. Tracey D. Tedder, Provost and Vice President of Academic Affairs at Florida Southern.
  • "Dr. Joseph is a vibrant and respected leader, with the experience to continue the tradition of excellence in the Ann Blanton Edwards School of Nursing and Health Sciences."
  • "I want to personally thank Dr. Kerr and the entire Board of Trustees at Florida Southern College for this opportunity," Dr. Joseph said.

Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration

Retrieved on: 
Thursday, June 8, 2023
Neurology, Biotechnology, Pharmaceutical, General Health, Health, Medical Devices, Genetics, Clinical Trials, GMP, Seizure, Good, Associate Director of National Intelligence and Chief Information Officer, DNA, Infantile neuroaxonal dystrophy, Plasmid, Good manufacturing practice, Therapy, Hearing loss, Neurodegenerative disease, Cognate, Display resolution, Mutation, Research, Life expectancy, Doctor of Philosophy, PLAN, HQ, CDMO, Patient, INAD, Drug discovery, Diagnosis, CRL, PLA2G6, Nerve, NYSE, Tecmar, Disease, Pharmaceutical industry, Vaccine

The collaboration will leverage Charles River’s market leading contract development and manufacturing organization (CDMO) expertise in High Quality (HQ) plasmid DNA production, to manufacture its leading candidate for Phase I/II clinical trials.

Key Points: 
  • The collaboration will leverage Charles River’s market leading contract development and manufacturing organization (CDMO) expertise in High Quality (HQ) plasmid DNA production, to manufacture its leading candidate for Phase I/II clinical trials.
  • Plasmid DNA is a critical starting material for many cell and gene therapy therapeutics and demand continues to outstrip supply.
  • In response to this, Charles River recently announced the opening of a state-of-the-art HQ plasmid manufacturing center of excellence to address these supply shortages and support the growing needs of the cell and gene therapy field.
  • Their invaluable expertise will undoubtedly contribute to the advancement of our gene therapy program.” - Leena Panwala, Founder & Executive Director at INADcure.

Decimal Point Analytics and PRMIA Collaborate for Successful "Quantifying ESG Risk" Event

Retrieved on: 
Monday, June 5, 2023
Associate Director of National Intelligence and Chief Information Officer, New York Bar Association, Shailesh Kumar, Risk, Fordham University, Disclosure, International Association, Risk assessment, PRMIA, Investment, ESG, Tourism, Risk management

NEW YORK, June 5, 2023 /PRNewswire/ -- Decimal Point Analytics , a leading provider of data analytics solutions, partnered with the Professional Risk Managers' International Association (PRMIA) to host the highly successful "Quantifying ESG Risk" event.

Key Points: 
  • NEW YORK, June 5, 2023 /PRNewswire/ -- Decimal Point Analytics , a leading provider of data analytics solutions, partnered with the Professional Risk Managers' International Association (PRMIA) to host the highly successful "Quantifying ESG Risk" event.
  • The event brought together industry professionals, investors, and experts in environmental, social, and governance (ESG) to explore the critical role of data analytics in assessing ESG risk.
  • The keynote session was delivered by Shailesh Dhuri, CEO of Decimal Point Analytics , who shared his expertise and insights on the significance of data analytics in ESG risk assessment.
  • "We are proud to have collaborated with PRMIA for the successful 'Quantifying ESG Risk' event," said Shailesh Dhuri, CEO of Decimal Point Analytics .

Building in Solutions for Anticipated Challenges in CAR T Development Programs, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, May 25, 2023
Associate Director of National Intelligence and Chief Information Officer, Drug development, Therapy, Hope, MBA, Research, PMP, Doctor of Philosophy, CAR, Rare, Project management, Patient, Diversity, CCRP, Pharmaceutical industry, Oncology

TORONTO, May 25, 2023 /PRNewswire-PRWeb/ -- CAR T-cell therapies are fundamentally changing the landscape of cancer treatment. Successful commercialization of multiple CAR T treatments, plus continued advancements in the technologies, combine to make this a very active segment of drug development. Despite the excitement and hope they have brought to the patient and research communities, the sponsors developing these therapeutics are encountering challenges that have delayed and seriously threatened the advancement of their programs. These therapies require specialized sites, recruitment strategies and clinical development partners experienced in delivery of these complex programs.

Key Points: 
  • Successful commercialization of multiple CAR T treatments, plus continued advancements in the technologies, combine to make this a very active segment of drug development.
  • In this webinar, attendees will hear from speakers partnering with the sponsors developing novel CAR T therapeutics.
  • Register to hear these speakers address the most common challenges and questions they hear from their CAR T sponsors.
  • Register today for an informative overview of how to address the challenges arising in CAR T-cell development programs.

Wunderkind Launches WunderKIND Ads To Address Advertising's Biggest Challenges

Retrieved on: 
Tuesday, May 23, 2023
KPI, Attention, Associate Director of National Intelligence and Chief Information Officer, Kindness, Advertising, IBM, Partnership, KFC, Dell, Meta, Post, DSP, Prodigy (rapper), Dentsu, Consumer, Mediacom, CPM, Apple, Empathy, ROI, Coca-Cola, Sales, Television, Online shopping, Programmatic Commerce, Child prodigy, Paramount

NEW YORK, May 23, 2023 /PRNewswire-PRWeb/ -- Wunderkind, a leading digital marketing solution for performance marketing and advertising - announced today the launch of WunderKIND Ads in order to help publishers and advertising partners deliver an unparalleled user-first ad experience.

Key Points: 
  • The WunderKIND Ads product now offers additional ways to measure media performance with advanced analytics partners.
  • Brands such as Coca-Cola, Apple, KFC, IBM, Dell, Paramount, and many others are already using WunderKIND ads with impressive results.
  • WunderKIND Ads was developed in response to a growing need for more elegant advertising solutions designed to address many of today's advertising challenges.
  • WunderKIND Ads address this reality by serving relevant ads to online visitors only after they have finished their browsing experience.

Participant Engagement and Realities in Decentralized Clinical Trials, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, May 22, 2023
Associate Director of National Intelligence and Chief Information Officer, Medicine, Head, Clinical trial, Research, DCT, Patient, Syneos Health, Site, Digital, Pharmaceutical industry, Nursing, DCTS

TORONTO, May 22, 2023 /PRNewswire-PRWeb/ -- Today's clinical trial landscape offers an unprecedented range of decentralized and hybrid options, including home health and community-based options. Digital solutions have been hailed as the path toward more inclusive trials yet many still struggle to recruit representative patient populations, despite clear regulatory guidance. How can the feedback from participants in recent clinical trials help industry refine its decentralized clinical trial (DCT) approach to be even more inclusive and responsive to patient preferences? How can industry work more collaboratively with advocates who possess distinct lines of site into their communities' needs and experiences around trial participation? In this webinar, the featured speakers will explore solutions to maximizing participant engagement in DCTs.

Key Points: 
  • TORONTO, May 22, 2023 /PRNewswire-PRWeb/ -- Today's clinical trial landscape offers an unprecedented range of decentralized and hybrid options, including home health and community-based options.
  • How can the feedback from participants in recent clinical trials help industry refine its decentralized clinical trial (DCT) approach to be even more inclusive and responsive to patient preferences?
  • In this webinar, the featured speakers will explore solutions to maximizing participant engagement in DCTs.
  • Register today and learn how incorporating patient insights and preferences into decentralized clinical trials can improve inclusivity and increase participant engagement.

Patient Centricity in Clinical Trials -- The Trinity of Patient, Sites and Sponsors, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, May 22, 2023
Medical Communications for Combat Casualty Care, Associate Director of National Intelligence and Chief Information Officer, PPD, Clinical trial, Concierge, Health, Patient, Pharmacist, Nursing

TORONTO, May 22, 2023 /PRNewswire-PRWeb/ -- Patient-centricity and patient diversity are challenging goals that all clinical trial sponsors seek to attain. The ever-rising cost of patient retention in clinical trials has highlighted patient engagement and the flexibility required by the industry to meet patients where they are and make clinical trial participation easier and more customized to their needs. The webinar will present two tactics employed by PPD to address these challenges.

Key Points: 
  • Attendees will explore how Virtual Research Coordination (VRCC) can help with attracting a more diverse patient population.
  • The featured speakers will discuss both offerings from the perspective of the patient, site and the sponsor.
  • TORONTO, May 22, 2023 /PRNewswire-PRWeb/ -- Patient-centricity and patient diversity are challenging goals that all clinical trial sponsors seek to attain.
  • The Patient Concierge program focuses on 24/7 1:1 support for patients throughout the duration of the trial.

The Veteran Jobs Mission Charts a Path Forward with the Formation of an Advisory Board

Retrieved on: 
Wednesday, May 17, 2023
Finance, Defense, Professional Services, Other Defense, Human Resources, JPMorgan Chase, Lead, Associate Director of National Intelligence and Chief Information Officer, Unemployment, Problem solving, U.S. Department of Defense Strategy for Operating in Cyberspace, United States Department of Defense, Caterpillar Inc., Veteran, VJM, U.S. Department of Labor, Office of Inspector General, Acqui-hiring, Veterans' affairs, Johnson & Johnson, Verizon Communications, Labour, Management

Composed of 12 elected board members, a senior advisor and a board chair, the inaugural VJM Advisory Board is set to meet for the first time today in Washington D.C.

Key Points: 
  • Composed of 12 elected board members, a senior advisor and a board chair, the inaugural VJM Advisory Board is set to meet for the first time today in Washington D.C.
  • In 2022, the coalition increased its goal of hiring two million veterans and 200,000 military spouses over the next decade.
  • “The military community brings immense value, diverse talent and robust skills into their next careers whether it be leadership, problem solving, teamwork, resilience and so much more,” said Mark Elliott, Veteran Jobs Mission Advisory Board Chair and Global Head of Military and Veterans Affairs at JPMorgan Chase, a founding member of the Veteran Jobs Mission.
  • With the new advisory board, the VJM will now have a strong governance structure in place to help further its mission of supporting military families by addressing the existing barriers to veteran and military spouse employment.

Bi-Coastal Advisor Team Joins IEQ Capital in San Francisco and Boston

Retrieved on: 
Monday, May 15, 2023
San Francisco, Associate Director of National Intelligence and Chief Information Officer, Wenner, Associate, SR, SAN, Jeremy Adam Smith, Management, Cryptocurrency, San Francisco Bay Area

Wenner and Beard, along with five team members, have a combined 50 years of experience in the capital markets and wealth management industries.

Key Points: 
  • Wenner and Beard, along with five team members, have a combined 50 years of experience in the capital markets and wealth management industries.
  • "We are delighted to welcome Jeremy, Adam, and their team to IEQ Capital.
  • Joining Wenner and Beard at IEQ Capital are team members Stephen Griffiths, Sr. Director, and Sanhita Bhattacharya, Sr.
  • Associate, in Boston, along with Dan Fleming, Associate Director, Jonathan Barnes, Associate Director, and Collin Sapp, Associate, in the San Francisco Bay Area.